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methicillin resistance has increased. The efficacy of mac-
rolide antibiotics in the treatment of infections caused by 
multi-resistant staphylococci makes them the most often 
prescribed drugs in clinical medicine. How ever, the ex-
panded use of these antibiotics has been accompanied 
by increased resistance rates among staphylococci all over 
the world.1,2
Macrolide antibiotic resistance in Staphylococcus aureus 
and coagulase-negative staphylococci (CoNS) may be due to 
an active drug efflux mechanism encoded by msrA and msrB 
(conferring resistance to macrolides and type B strepto-
gramins only) or may be the result of ribosomal target mod-
ification, mediated by the presence of erm genes [erm(A), 
erm(B) and erm(C)] conferring resistance to macrolides, 
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This study investigated the prevalence of genes encoding resistance to macrolides, lincosamides and strep-
togramins (MLSB) among staphylococci in a series of 301 erythromycin-resistant clinical isolates of 
Staphylococcus aureus and coagulase-negative staphylococci (CoNS). Erythromycin-resistance phenotypes 
were determined according to Clinical and Laboratory Standards Institute guidelines and specific resis-
tance genes erm(A), erm(B), erm(C), msr(A) and msr(B) were identified using polymerase chain reaction. Two 
hundred of 301 (66.5%) erythromycin-resistant staphylococcal isolates exhibited resistance to MLSB anti-
biotics. Of these, 127 (63.5%) exhibited a cMLSB resistance phenotype (resistant to both erythromycin and 
clindamycin), whereas 73 (36.5%) expressed the iMLSB resistance phenotype (resistant to erythromycin 
and susceptible to clindamycin). The most prevalent resistance determinants were erm(A) (62%) among 
S. aureus and erm(C) (30%) among CoNS isolates. Combinations of resistance mechanisms were rarely 
seen, and occurred most often in oxacillin-resistant isolates. The results of the present study support the 
idea that there are geographical differences in the prevalence of erythromycin resistance mechanisms 
among staphylococci, therefore local surveillance studies are important tools for guiding therapy and in 
the promotion of judicious use of antimicrobial agents.
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Introduction
Empirical outpatient treatment options for staphy-
lococcal infections have become more limited as 
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lincosamides, and type B streptogramins (MLSB resis-
tance).2,3 When the underlying mechanism of resistance to 
erythromycin is an altered efflux system, expressed by the 
msrA/msrB gene, staphylococcal strains are susceptible to 
clindamycin, whereas ribosomal methylation expressed by 
the erm gene could render strains resistant to clindamycin. 
Phenotypic expression of MLSB resistance in staphylococci 
can be either inducible or constitutive. Strains with induc-
ible MLSB (iMLSB) resistance demonstrate in vitro resistance 
to 14- and 15-member macrolides, but appear susceptible to 
16-member macrolides, lincosamides and type B strepto-
gramins. Strains with constitutive MLSB (cMLSB) resistance 
are considered resistant to all MLSB-type antibiotics, al-
though streptogramin A-type antibiotics escape resistance.2
Although there is growing data regarding the preva-
lence of MLSB resistance phenotypes among staphylococ-
cal isolates from different regions of Turkey,4–8 data on 
the genetic determinants of MLSB resistance are limited.9,10 
The present study was undertaken to investigate the prev-
alence of genes encoding resistance to MLSB antibiotics in 
a series of 301 erythromycin-resistant clinical isolates of 
S. aureus and CoNS.
Methods
Bacterial isolates
This study included 301 erythromycin-resistant staphylo-
coccal isolates consisting of 47 S. aureus [32 methicillin-
resistant S. aureus (MRSA) and 15 methicillin-susceptible 
S. aureus (MSSA)] and 254 CoNS [161 methicillin-resistant 
CoNS (MRCoNS) and 93 methicillin-susceptible CoNS 
(MSCoNS)], collected between January 2006 and January 
2007 in the Clinical Microbiology Laboratory of the Faculty 
of Medicine, Suleyman Demirel University (Isparta, Turkey). 
All staphylococcal isolates determined to be resistant to 
erythromycin and clinically significant based on species 
identification were included in the study. Duplicate iso-
lates from the same patients were excluded. Isolates were 
characterized to the species level by Gram staining, cata-
lase, slide and tube coagulase and by biochemical tests (API 
Staph; bioMerieux, Marcy l’Etoile, France).
Susceptibility testing
Erythromycin and oxacillin susceptibilities of the strains 
were determined by the Kirby–Bauer disk diffusion 
method following the criteria of the Clinical and Labora-
tory Standards Institute.11 The resistance phenotypes of 
erythromycin-resistant isolates were determined by the 
double-disk test method in accordance with the recom-
mendations of the Clinical and Laboratory Standards 
Institute. S. aureus ATCC BAA-977 was used as a positive 
control for iMLSB resistance and S. aureus ATCC 25923 
was used as a control for the other tested antibiotics.
Polymerase chain reaction amplification of MLSB 
resistance genes
Polymerase chain reaction (PCR) was carried out on the 
301 staphylococcal strains displaying resistance to eryth-
romycin. Genomic DNA was extracted from staphylococcal 
cultures using a genomic DNA purification kit (Fermentas 
Life Sciences) and used as a template for amplification. 
Extracted DNA was stored at –20°C until PCR was per-
formed. The erm(A), erm(B), erm(C), msr(A) and msr(B) 
genes were detected by PCR using the oligonucleotide 
primer pairs described by Lim et al1 and Spiliopoulou 
et al.12 These oligonucleotides were synthesized by Bio 
Basic Inc (Canada).
Five different PCRs were run for each isolate. Each 
reaction was carried out in a final volume of 50 μL and 
included 5 μL of 10× PCR buffer [100 mM Tris-HCl (pH 
8.8 at 25°C), 500 mM KCl] (Fermentas), 2 mM MgCl2 
(Fermentas), 0.2 mM each of dATP, dTTP, dCTP and 
dGTP (Fermentas), 0.4 mM of the sense and anti-sense 
primers, 1.25 U Taq DNA polymerase (Fermentas) and 1 μL 
of extracted template DNA. The PCR were initialized by a 
denaturation step (5 min at 94°C) followed by 35 cycles of 
30 seconds at 95°C, 30 seconds at 54°C, 1 minute at 72°C; 
and a final extension step (5 min at 72°C). PCR products 
were detected by gel electrophoresis (100 V, 60 min) in 
2% (w/v) agarose gels containing ethidium bromide. The 
sizes of the PCR products were estimated with standard 
molecular weight markers (1.5–100 kb DNA ladder; Bio 
Basic Inc., Ontario, Canada). Isolates were considered 
positive for erm(A), erm(B), erm(C), msr(A) and msr(B) genes 
when the respective PCR products of the expected size 
could be visualized.
Statistical analysis
Statistical analysis was conducted using Fischer’s exact 
test and χ2 test.
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Results
MLSB resistance phenotypes
Two hundred (66%) of the 301 erythromycin-resistant sta-
phylococcal isolates exhibited resistance to MLSB antibi-
otics; of these, 127 (64%) exhibited a cMLSB resistance 
phenotype, whereas 73 (37%) expressed the iMLSB resis-
tance phenotype. It was observed that 40 (85%) of 47 
S. aureus and 160 (63%) of 254 CoNS isolates exhibited MLSB 
resistance. Approximately 44% of CoNS isolates expressed 
the cMLSB phenotype, and 19% expressed the iMLSB phe-
notype whereas 51% of S. aureus isolates expressed cMLSB 
and 34% expressed the iMLSB phenotype. When the resis-
tance rates were evaluated according to oxacillin resistance 
of the strains, 29 of 32 (91%) MRSA, 11 of 15 (73%) MSSA, 
112 of 161 (70%) MRCoNS, and 48 of 93 (52%) MSCoNS 
displayed MLSB resistance. cMLSB was detected in 89 of 
161 (55%) MRCoNS, 14 of 32 (44%) MRSA, 22 of 93 (24%) 
MSCoNS and 2 of 15 (13%) MSSA. iMLSB was detected in 
9 of 15 (60%) MSSA, 15 of 32 (47%) MRSA, 26 of 93 (28%) 
MSCoNS, and 23 of 161 (14%) MRCoNS. MLSB resistance 
was more prevalent among S. aureus strains, and oxacillin-
resistant strains exhibited significantly higher MLSB re-
sistance rates compared with oxacillin-susceptible strains 
(p < 0.001). The most frequently detected resistance phe-
notype among all erythromycin-resistant staphylo coccal 
isolates was the constitutive type and this resis tance 
phenotype was more frequently encountered among 
oxacillin-resistant strains. Additionally, the iMLSB resis-
tance phenotype was significantly higher among S. aureus 
than CoNS strains (p < 0.001).
MLSB resistance genotypes
The distribution of resistance genes is presented in the 
Table. The most prevalent resistance determinant among 
S. aureus was erm(A), which was detected in 62% (29/47) 
of the isolates. The erm(C) determinant was found as a 
single MLSB resistance gene in eight (17%) S. aureus iso-
lates while three isolates (6%) contained both erm(A) and 
erm(C). msrA/B genes were detected among 13 S. aureus 
isolates (27%). The most prevalent resistance determinant 
among CoNS was erm(C), which was detected in 30% 
(77/254) of the isolates. The erm(A) determinant was found 
as a single MLSB resistance gene in 44 (17%) CoNS isolates 
while 11 isolates (4%) contained both erm(A) and erm(C), 
and msrA/B genes were detected among 81 CoNS isolates 
(32%). Erm(B) was detected only in three MRCoNS strains 
with the cMLSB resistance phenotype and one of these 
strains also contained erm(C).
Combinations of resistance mechanisms were rarely 
seen, and occurred mainly in oxacillin-resistant isolates. 
Eighty-three of the erythromycin-resistant isolates did not 
harbor any of the tested resistance mechanisms. Seventy-
seven of these isolates were CoNS, while only six were 
S. aureus.
Discussion
While data on genetic determinants of MLS resistance 
from Turkey are limited to the reports of Aktas et al and 
Saribas et al,9,10 other groups have studied the prevalence 
of MLS resistance using phenotypic methods in other hos-
pitals from Turkey.4–8 While the MLSB resistance rate deter-
mined in our hospital was higher than the rate reported 
by Tunckanat and Arikan,8 it was lower than the rate re-
ported by Delialioglu et al.6 Overall, the most frequently 
determined genetic determinant responsible for MLSB re-
sistance was erm(C), with a constitutive resistance pheno-
type in our study. This finding was in accordance with 
previous reports from Turkey.9,10 Aktas et al reported that 
57.8% of CoNS isolates expressed the cMLSB phenotype 
and 20.6% expressed iMLSB. These rates were similar to the 
rates we detected (44% and 19%, respectively) for CoNS 
isolates. However, Aktas et al also reported that 78.2% of 
their CoNS isolates harbored the erm(C) gene and 8.9% 
had erm(A). The prevalence rates we detected were 30% for 
erm(C) and 17% for erm(A). Aktas et al reported that in 
S. aureus, cMLSB (58.3%) was more common than the 
inducible phenotype (20.8%) and erm(A) was detected 
in 50% and erm(C) in 62.5% of the isolates.9 Saribas et al10 
reported that cMLSB was more common (64%) than the 
inducible phenotype (36%), and their findings were in ac-
cordance with Aktas et al. This contrasted with our study 
in which the most prevalent phenotype among S. aureus 
detected was the iMLSB type (51%) mediated by the erm(A) 
(62%) genes. While our findings for S. aureus isolates differ 
with the two studies from Turkey and from the results of 
Spiliopoulou et al12 and Schmitz et al13 (both of which 
also identified a predominance of the erm(C) gene among 
S. aureus), other published studies agreed with our finding 
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that erm(A) was the most frequent genetic determinant 
among S. aureus.14–16 The most prevalent resistance deter-
minant was erm(C) in CoNS isolates in our study and these 
results are confirmed by those of Reyes et al, Chaib et al, 
Eady et al, and Gatermann et al, who documented the 
predominance of erm(C) in a large series of clinical and 
commensal CoNS isolates.16–19 Thus, in conjunction with 
previous reports, the results of the present study support 
the hypothesis that there are geographical differences in 
the prevalence of erythromycin resistance mechanisms 
among staphylococci.2
However, we must also mention the fact that since spe-
cies identification was not performed for CoNS isolates, 
we cannot exclude the possibility that these differences 
might be due to variation in the distribution of different 
species. Most of the isolates from which we were not able 
to detect any resistance genes were CoNS, and this was 
in accordance with the previous reports that have found 
Table. Distribution of resistance genes among 301 erythromycin-resistant staphylococci isolatesa
Isolate Resistance type Erm A Erm B Erm C Erm A + C msrA/B Erm + msr ND
S. aureus (n = 47) iMLSB (n = 24) 14 0 6 1 7 5 3
 cMLSB (n = 16) 15 0 2 2 2 1 0
 MLSBØ (n = 7) 0 0 0 0 4 0 3
 Total (n =  47) 29 (62) 0 8 (17) 3 (6) 13 (27) 6 (13) 6 (13)
MRSA (n = 32) iMLSB (n = 15) 9 0 4 1 2 2 3
 cMLSB (n = 14) 13 0 2 2 2 1 0
 MLSBØ (n = 3) 0 0 0 0 2 0 1
 Total (n = 32) 22 0 6 3 6 3 4
MSSA (n = 15) iMLSB (n = 9) 5 0 2 0 5 3 0
 cMLSB (n = 2) 2 0 0 0 0 0 0
 MLSBØ (n = 4) 0 0 0 0 2 0 2
 Total (n = 15) 7 0 2 0 6 2 2
CoNS (n = 254) iMLSB (n = 49) 11 0 21 3 6 3 17
 cMLSB (n = 111) 33 3 56 8 28 13 13
 MLSBØ (n = 94) 0 0 0 0 47 0 47
 Total (n = 254) 44 (17) 3 (1) 77 (30) 11 (4) 81 (32) 16 (6) 77 (30)
MRCoNS (n = 161) iMLSB (n = 23) 9 0 15 3 3 3 2
 cMLSB (n = 89) 23 3 48 6 25 13 10
 MLSBØ (n = 49) 0 0 0 0 29 0 20
 Total (n = 161) 32 3 63 9 57 16 32
MSCoNS (n = 93) iMLSB (n = 26) 2 0 6 0 3 0 15
 cMLSB (n = 22) 10 0 8 2 3 0 3
 MLSBØ (n = 45) 0 0 0 0 18 0 27
 Total (n = 93) 12 0 14 2 24 0 45
Total (n = 301) iMLSB (n = 73) 25 0 27 4 13 8 20
 cMLSB (n = 127) 48 3 58 10 30 14 13
 MLSBØ (n = 101) 0 0 0 0 51 0 50
 Total (n = 301) 73 (24) 3 (1) 85 (28) 14 (5) 94 (31) 22 (7) 83 (28)
aData presented as n (%). ND = Not detected; S. aureus = Staphylococcus aureus; iMLS = inducible macrolide, lincosamide and streptogramin resistance; 
cMLS = constitutive macrolide, lincosamide and streptogramin resistance; MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillin-
susceptible Staphylococcus aureus; CoNS = coagulase-negative staphylococci; MRCoNS = methicillin-resistant coagulase-negative staphylococci; 
MSCoNS = methicillin-susceptible coagulase-negative staphylococci.
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unidentified resistance mechanisms in a considerable 
proportion of CoNS isolates.1 It is likely that other eryth-
romycin resistance genes such as Ere A–B or mef, which 
we did not include in our study, might be present among 
these isolates.3
The main problem among strains that have been 
detected as erythromycin resistant and clindamycin sus-
ceptible by standard antibiotic susceptibility tests is the 
possibility that these strains may be inducibly resis tant 
to MLSB antibiotics, since this resistance phenotype can 
be underestimated if testing for inducible resistance is 
not performed. Although most erythromycin-resistant 
isolates in the present study showed constitutive expression 
of MLSB resistance, 24 (77%) of 31 S. aureus and 49 (34%) 
of 143 CoNS isolates that were erythromycin resistant 
and clindamycin susceptible were positive by the D-test. 
Therefore, we suggest that erythromycin-resistant isolates 
of S. aureus may also be considered to be clindamycin
resistant in most cases. Although clindamycin is reported 
as one of the therapeutic options in the treatment of 
MRSA,20 it seems that we cannot consider this antibiotic 
as useful in the treatment of hospital-associated MRSA 
infections. However, the lower positivity rate by the D-test 
among erythromycin-resistant CoNS made us think that 
clindamycin should not be considered to be ineffective in 
these species without testing for inducible resistance. It has 
been reported that resistance mechanisms other than meth-
ylation are more common among CoNS, the assumption 
being that methylases are responsible for erythromycin 
resistance in these isolates could lead to an unnecessary 
avoidance of lincosamides and an increased usage of 
glycopeptides.14
In conclusion, the most prevalent phenotype among 
S. aureus was the iMLSB type mediated by the erm(A) gene, 
while the most prevalent phenotype among CoNS was 
the cMLSB type mediated by erm(C) gene. These findings 
with significant geographical differences in resistance 
patterns and resistance rates make the results of local sur-
veillance studies an important tool in guiding therapy 
and for judicious use of antimicrobial agents.
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